[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370406-105":59,"doc-detail-370406-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","predictive-and-clinicopathological-importance-of-hmgb2-in-various-carcinomas-a-meta-and-bioinformatic-approach","Predictive and clinicopathological importance of HMGB2 in various carcinomas - a meta and bioinformatic approach","","High mobility group box 2 (HMGB2) is evaluated for its prognostic and clinicopathological relevance across multiple cancer types. A systematic search of PubMed, Web of Science, Embase, CNKI, and Wanfang was used to perform a quantitative meta-analysis, estimating hazard ratios for overall survival and disease-free survival, alongside clinicopathological features. Seventeen studies covering 2555 patients were included. Results show high HMGB2 correlates with worse outcomes, and GEPIA supports HMGB2 upregulation in most cancers with specific downregulation in LAML.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predictive-and-clinicopathological-importance-of-hmgb2-in-various-carcinomas-a-meta-and-bioinformatic-approach/370406/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predictive-and-clinicopathological-importance-of-hmgb2-in-various-carcinomas-a-meta-and-bioinformatic-approach/370406.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was HMGB2 evaluated in the study?","Question",{"text":112,"@type":113},"The study combined a systematic meta-analysis of published literature with bioinformatic validation using the GEPIA online platform to assess HMGB2 expression patterns across cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the relationship between high HMGB2 expression and patient prognosis?",{"text":117,"@type":113},"High HMGB2 expression was significantly associated with shorter overall survival, indicating a detrimental prognostic effect across the analyzed carcinomas.",{"name":119,"@type":110,"acceptedAnswer":120},"What statistical approach was used to estimate survival impact?",{"text":121,"@type":113},"Hazard ratios with 95% confidence intervals were computed to quantify the relationship between HMGB2 expression levels and overall survival and disease-free survival, using tools such as StataMP16 and RevMan 5.3.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370406,1790495542,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPredictive and clinicopathological importance of HMGB2 in various carcinomas: a meta and bioinformatic approach  \nYinan Zhu, Siyu He, Ziyue Wang, Haiyan Xi, Wanchen Lu & Xuyong Lin􀀍  \nBackground: High mobility group box 2 (HMGB2), one of the HMGB domain proteins, may play a significant role in cancer development and progression. Recent scientific investigations have hinted atthe potential clinical relevance of HMGB2, particularly in cancer patients where its expression levels have been observed to be elevated. However, the precise impact of HMGB2 on the prognosis of tumors remains an area of ongoing research. To the best of our understanding, our study represents a metaanalysis that elucidates a connection between HMGB2 expression and the clinical outcomes of diverse cancer types. Method: We executed a thorough and systematic search of literature across PubMed, Web of Science, Embase, CNKI, and Wanfang databases. Following this, we conducted a quantitative meta-analysis using statistical tools such as StataMP16 and RevMan5.3. The primary focus of our analysis was to assess the relationship between HMGB2 expression levels and overall survival (OS), disease-free survival (DFS), as well as various clinicopathological characteristics of cancer patients by calculating the hazard ratio (HR). Additionally, we validated our findings by examining HMGB2 expression patterns across different cancer types using the Gene Expression Profiling Interactive Analysis (GEPIA) online platform. Result: Our meta-analysis incorporated data from 17 studies, encompassing a total of 2555 cancer patients. The results revealed a statistically significant association between high HMGB2 expression and shorter OS (HR, 1.40 ;95% CI: 1.10–1.70; P \u003C 0.001), especially in digestive cancer ( HR, 2.09 (95% CI: 1.54–2.63; I2 = 0.0%,P = 0.424) . Furthermore, GEPIA analysis demonstrated a consistent upregulation of HMGB2 in most cancer types, with a downregulation between HMGB2 and LAML. Conclusion: Our findings underscore a detrimental correlation between the upregulation of HMGB2 and the prognosis of various cancers. This discovery could pave the way for the development of innovative prognostic biomarkers and therapeutic targets that specifically target HMGB2, offering new avenues for the management and treatment of cancer patients.  \nIn recent years, cancer has emerged as one of the foremost public health challenges and the major causes of death worldwide, accounting for nearly 10 million deaths in 20201. In China, the incidence of cancer is also on the rise. 4.5 million new cancer cases and 3 million deaths occurred in China in 2020, accounting for 25% and 30% of global cases, respectively2. Given the substantial burden that tumors impose on individuals and societies worldwide, there is an urgent need to identify effective biomarkers for early detection and timely intervention. However, the number of clinically validated tumor markers remains limited.The identification of new biomarkers for cancer diagnosis or prognosis has become increasingly meaningful.  \nHigh mobility group box 2 (HMGB2), also called HMG2, is one of the HMGB domain proteins, located at 4q34.1. As part of the HMG superfamily (High-Mobility Group), the HMGB2 (as well as HMGB1 and HMGB3) is highly expressed in all tissues during embryogenesis in mammals3. The proteins of this family are chromatinassociated and ubiquitously distributed in the nucleus of higher eukaryotic cells. HMGB2 has been implicated in various biological processes, including DNA repair, transcription regulation, and inflammation. It is important in facilitating cooperative interactions between cis-acting proteins by promoting DNA flexibility. Yi Huang4 et al. identified HMGB2 as a a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis. Recent studies have suggested that HMGB2 plays a significant role in cancer develop","cbCaioIdLceAzlGO","https://ap.wps.com/l/cbCaioIdLceAzlGO","pdf",5181248,15,"English","# Materials and methods\n## Literature search strategy\n## Study selection\n## Meta-analysis and statistical assessment\n## Bioinformatic validation using GEPIA\n# Results\n## Overall survival and disease-free survival associations\n## Clinicopathological correlations\n## GEPIA expression patterns\n# Conclusion","[{\"question\":\"How was HMGB2 evaluated in the study?\",\"answer\":\"The study combined a systematic meta-analysis of published literature with bioinformatic validation using the GEPIA online platform to assess HMGB2 expression patterns across cancer types.\"},{\"question\":\"What is the relationship between high HMGB2 expression and patient prognosis?\",\"answer\":\"High HMGB2 expression was significantly associated with shorter overall survival, indicating a detrimental prognostic effect across the analyzed carcinomas.\"},{\"question\":\"What statistical approach was used to estimate survival impact?\",\"answer\":\"Hazard ratios with 95% confidence intervals were computed to quantify the relationship between HMGB2 expression levels and overall survival and disease-free survival, using tools such as StataMP16 and RevMan 5.3.\"}]","Predictive and clinicopathological importance of HMGB2 in various carcinomas - a meta and bioinformatic approach | PDF",1790188369,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c12d70f0cdb174a9ed00ce75c4bfe110.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f2232f8235f43fcdca7a359a1eca31a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ca6b254a4dbbf1f5aea359d3bb1a8e0.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ded36f01880a1763222aa93f1cc8a083.webp",980,1287]